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BACKGROUND: Herein, we report a case of systemic cutaneous T-cell lymphoma
refractory to standard therapy, the course of which resulted in haplo-identical bone
marrow grafting.
PATIENTS AND METHODS: A 53-year-old woman consulted for facial erythema
with infiltration, keratotic lesions on the trunk, and adenopathies measuring
around 1cm on the axilla and inguinal folds. A diagnosis was made of Sézary
syndrome (SS), a leukaemic form of epidermotropic cutaneous T-cell lymphoma.
After three years of treatment with methotrexate, the patient developed
transformed SS with visceral involvement. Given the high risk of relapse and the
absence of an HLA-compatible donor, haploidentical bone marrow grafting was
performed. The patient was still in complete remission two and a half years later.
The disease course was nevertheless marked by the emergence one year after
grafting of a Blaschko-distributed lichenoid eruption having histological features
consistent with chronic graft-versus-host disease (GVHD); treatment with topical
betamethasone proved efficacious.
DISCUSSION: To our knowledge, this is the first reported case of haploidentical
grafting for systemic and transformed cutaneous T-cell lymphoma. This approach
could henceforth represent a therapeutic option for patients requiring an allograft
in the absence of compatible donors. The Blaschko-distributed lichenoid lesions
attributed to chronic GVHD could be the result of reduced immune tolerance to
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